{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:08:09Z","timestamp":1784956089752,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.metop.2021.100080","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T11:50:46Z","timestamp":1611834646000},"page":"100080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The use of metformin as an add-on therapy to insulin in the treatment of poorly controlled type 1 diabetes mellitus in adolescents"],"prefix":"10.1016","volume":"9","author":[{"given":"Katsiaryna","family":"Sikorskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Zarzecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzoamaka","family":"Ejikeme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metop.2021.100080_bib1","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.metop.2021.100080_bib33","unstructured":"Centers for Disease Control and Prevention. (n.d.-b). Diabetes in youth. https:\/\/www.cdc.gov\/diabetes\/library\/reports\/reportcard\/diabetes-in-youth-2017.html."},{"key":"10.1016\/j.metop.2021.100080_bib3","unstructured":"American Diabetes Association. (n.d.). https:\/\/www.diabetes.org\/diabetes\/type-1\/symptoms."},{"issue":"7","key":"10.1016\/j.metop.2021.100080_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/2230-8210.155402","article-title":"Puberty and type 1 diabetes","volume":"19","author":"Chowdhury","year":"2015","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"issue":"9","key":"10.1016\/j.metop.2021.100080_bib5","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/dci18-0023","article-title":"Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association","volume":"41","author":"Chiang","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.metop.2021.100080_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1758-5996-5-6","article-title":"Metformin: an old but still the best treatment for type 2 diabetes","volume":"5","author":"Rojas","year":"2013","journal-title":"Diabetol Metab Syndrome"},{"issue":"9","key":"10.1016\/j.metop.2021.100080_bib34","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.metop.2021.100080_bib9","series-title":"Essentials of nursing research: appraising evidence for nursing practice","author":"Polit","year":"2018"},{"issue":"11","key":"10.1016\/j.metop.2021.100080_bib10","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jclinepi.2013.05.016","article-title":"Single-center trials tend to provide larger treatment effects than multicenter trials: a systematic review","volume":"66","author":"Unverzagt","year":"2013","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.metop.2021.100080_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s13410-015-0289-0","article-title":"The improvement of metabolic control after using metformin in patients with type 1 diabetes mellitus and excessive visceral fat tissue treated with intensive insulin therapy\u2014pilot study","volume":"35","author":"Zawada","year":"2015","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"4","key":"10.1016\/j.metop.2021.100080_bib11","article-title":"The effect of metformin as an adjunct therapy in adolescents with type 1 diabetes","volume":"11","author":"Setoodeh","year":"2017","journal-title":"J\u00a0Clin Diagn Res"},{"issue":"3","key":"10.1016\/j.metop.2021.100080_bib12","doi-asserted-by":"crossref","first-page":"686","DOI":"10.12669\/pjms.333.12669","article-title":"Comparison of adjunctive therapy with metformin and acarbose in patients with type-1 diabetes mellitus","volume":"33","author":"Ziaee","year":"2017","journal-title":"Pakistan Journal of Medical Sciences"},{"issue":"8","key":"10.1016\/j.metop.2021.100080_bib13","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1210\/jc.2019-00129","article-title":"Metformin improves peripheral insulin sensitivity in youth with type 1 diabetes","volume":"104","author":"Cree-Green","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"21","key":"10.1016\/j.metop.2021.100080_bib14","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1001\/jama.2015.16174","article-title":"Effect of metformin added to insulin on glycemic control among overweight\/obese adolescents with type 1 diabetes: a randomized clinical trial","volume":"314","author":"Libman","year":"2015","journal-title":"J\u00a0Am Med Assoc: JAMA, J Am Med Assoc"},{"issue":"25","key":"10.1016\/j.metop.2021.100080_bib7","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1161\/CIRCULATIONAHA.118.035525","article-title":"Metformin improves insulin sensitivity and vascular health in youth with type 1 diabetes mellitus","volume":"138","author":"Bjornstad","year":"2018","journal-title":"Circulation"},{"issue":"7\u20138","key":"10.1016\/j.metop.2021.100080_bib15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.20452\/pamw.3527","article-title":"Association between adjunctive metformin therapy in young type 1 diabetes patients with excess body fat and reduction of carotid intima-media thickness","volume":"126","author":"Burchardt","year":"2016","journal-title":"Pol Arch Med Wewn"},{"issue":"1","key":"10.1016\/j.metop.2021.100080_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4155\/cli.12.130","article-title":"Randomization in clinical trials: can we eliminate bias?","volume":"3","author":"Sverdlov","year":"2013","journal-title":"Clin Invest"},{"issue":"1","key":"10.1016\/j.metop.2021.100080_bib17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12933-016-0413-6","article-title":"Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study","volume":"15","author":"Ahmed","year":"2016","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.metop.2021.100080_bib18","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1210\/jc.2017-00781","article-title":"Effect of metformin on vascular function in children with type 1 diabetes: a 12-month randomized controlled trial","volume":"102","author":"Anderson","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.metop.2021.100080_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bcp.12150","article-title":"Overview of methods for comparing the efficacies of drugs in the absence of head-to-head clinical trial data","volume":"77","author":"Kim","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.metop.2021.100080_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/pedi.12140","article-title":"Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study","volume":"16","author":"Nadeau","year":"2015","journal-title":"Pediatr Diabetes"},{"issue":"17","key":"10.1016\/j.metop.2021.100080_bib21","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/CIR.0000000000000094","article-title":"Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association","volume":"130","author":"Maahs","year":"2014","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.metop.2021.100080_bib22","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2337\/dc11-2339","article-title":"Defining insulin resistance from hyperinsulinemic-euglycemic clamps","volume":"35","author":"Tam","year":"2012","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.metop.2021.100080_bib23","first-page":"1091","article-title":"Adverse drug reactions: predisposing factors, modern classifications and causality assessment","volume":"7","author":"Abubakar","year":"2014","journal-title":"Res J Pharm Technol"},{"issue":"1","key":"10.1016\/j.metop.2021.100080_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/0976-500X.179361","article-title":"Evaluation of inter-rater agreement between three causality assessment methods used in pharmacovigilance","volume":"7","author":"Thaker","year":"2016","journal-title":"J\u00a0Pharmacol Pharmacother"},{"issue":"2","key":"10.1016\/j.metop.2021.100080_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dci15-0013","article-title":"Mechanism of metformin: a tale of two sites","volume":"39","author":"Song","year":"2016","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.metop.2021.100080_bib32","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.metop.2021.100080_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00191","article-title":"Metformin and its benefits for various diseases","volume":"11","author":"Lv","year":"2020","journal-title":"Front Endocrinol"},{"issue":"10","key":"10.1016\/j.metop.2021.100080_bib27","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1210\/jc.2002-020517","article-title":"Association between the insulin resistance of puberty and the insulin-like growth factor-i\/growth hormone axis","volume":"87","author":"Moran","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"17","key":"10.1016\/j.metop.2021.100080_bib28","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1074\/jbc.CL119.008628","article-title":"The mystery of metformin","volume":"294","author":"Spiering","year":"2019","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.metop.2021.100080_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/2042018812465639","article-title":"Diabetes treatment in 2025: can scientific advances keep pace with prevalence?","volume":"3","author":"Shomali","year":"2012","journal-title":"Therapeutic Advances in Endocrinology and Metabolism"},{"issue":"22","key":"10.1016\/j.metop.2021.100080_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127524","article-title":"Cryo-EM as a powerful tool for drug discovery","volume":"30","author":"Van Drie","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"10.1016\/j.metop.2021.100080_bib35","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.chembiol.2018.07.006","article-title":"Cryo-EM for small molecules discovery, design, understanding, and application","volume":"25","author":"Scapin","year":"2018","journal-title":"Cell Chemical Biology"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936821000049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936821000049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:55:41Z","timestamp":1762905341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936821000049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":33,"alternative-id":["S2589936821000049"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2021.100080","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of metformin as an add-on therapy to insulin in the treatment of poorly controlled type 1 diabetes mellitus in adolescents","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2021.100080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100080"}}